Skip to main content
AIBD Event Banner
* indicates a required field

Call for Poster Abstract Submission

Welcome to the Poster Submission Portal for Advances in IBD 2023, which will be held at the Walt Disney World Dolphin Hotel from December 14-16, 2023.

Your comprehensive poster abstract proposal(s) MUST be submitted by Monday, September 25, 2023 at 11:59 PM ET to be considered for acceptance at this year's event. Abstracts are subject to acceptance by the Scientific Review Committee. Accepted abstracts will be published in the American Journal of Gastroenterology and accepted for poster display at the 2023 AIBD conference. Only abstracts received by the submission deadline will be considered. Acceptance notifications will be sent on or before October 30, 2023.

Abstracts will be accepted in the following categories: CLINICAL, SURGERY, PEDIATRIC, NURSING/APP, or YOUNG INVESTIGATOR. Please indicate which category is appropriate by checking the appropriate box in the online submission system.

  • Outcomes Research
  • Clinical Trials and IBD Therapies
  • Procedures and Diagnostics
  • Case Reports

  • Surgery

  • Pediatrics

  • Nurses/Advanced Practice Providers

  • Young Investigator

  • Abstract Guidelines
    Accepted Format:
  • Abstracts must be in English
  • 500-word count limit
  • Use a concise title in title case only. (Example: This is the Title of my Presentation)
  • List affiliations of ALL author(s)
  • Use standard and well-accepted abbreviations
  • References do not need to be submitted in the Abstract. Please include them in the final poster.
  • Abstract content should be single-spaced and typed in lower case; abstract title should not include any formatting
  • Abstracts shall be of original research and contain a concise statement of study aim
  • No uploaded tables or graphs shall be included in submitted abstract
  • Please include the following four (4) parts of your abstract: Background, Methods, Results, and Conclusion(s). Conclusions must be supported by your results and summarized within your abstract at the time of submission. Results “to be completed” and/or conclusions “to be discussed” are not acceptable

  • Previous Presentation, Publication and Duplication of Abstracts:
  • Encore abstracts will be allowed if they contain new data. During the submission process you will be asked if the abstract has been presented before, when you say yes you will be prompted to submit the original abstract as a reference
  • Abstracts will not be considered for presentation if they have been or will be published as an article (includes manuscripts accepted for publication) in either printed or electronic format upon the abstract submission deadline
  • Abstracts will not be considered for presentation if they have been duplicated in any way
  • Abstracts may not be submitted to more than one category
  • Abstracts that have been submitted to the Advances in IBD Conference in previous years, and have not been accepted for poster presentation, are eligible for submission but must contain new, additional information to be considered
  • Violations of these policies could result in a sanction from submitting abstracts to this conference for the submitting author

  • Poster Abstract Awards
    Abstracts are reviewed and accepted by the AIBD Scientific Review Committee. Each year the AIBD Scientific Review Committee recognizes the “Best Of” submitted abstracts. Winning abstracts receive free conference registration and a $500 scholarship to help off-set associated travel expenses. Abstract awards are given for the following categories: Clinical, Surgery, Pediatric, Nursing/APP, and Young Investigator.

    Submission of an abstract constitutes a commitment by the author(s) to 1) submit an appropriately formatted abstract poster to showcase in the AIBD poster hall, and 2) conduct an oral presentation if selected as the winning abstract for the category (i.e., Best of Surgery Abstract). Failure to present, if not justified, will jeopardize acceptance of future abstract submissions. Only the primary author or co-author may present the accepted abstract at the 2022 Advances in IBD Conference.

    The conference will withdraw abstracts upon written notification from the submitting author by October 15, 2022. Acceptance of the abstract obligates the author to present the paper.

    Industry authors can be a co-author, but they cannot be the lead and/or senior author. Further, Industry authors cannot be the ones to present the research on site at AIBD. There are absolutely no exceptions to this rule.

    Please refer to our website ( for FAQs and more information regarding poster abstracts.

    Log in to the Poster Abstract Submission Portal

    Questions? Organizer: Kathleen Krause -